Market Place
Sourcing Support
All News #Library
Biotech
Grace Therapeutics Announces STRIVE-ON Phase 3 Abstract at AAN
14 Apr 2026 //
GLOBENEWSWIRE
Grace to Present Data on GTx-104 in the Treatment of aSAH
19 Mar 2026 //
GLOBENEWSWIRE
Grace Therapeutics To Join TD Cowen 46th Health Care Conference
25 Feb 2026 //
GLOBENEWSWIRE
Grace Therapeutics Reveals Q3 2026 Financials, Updates Business
12 Feb 2026 //
GLOBENEWSWIRE
Grace Therapeutics To Attend Craig-Hallum Alpha Select Conference
17 Nov 2025 //
GLOBENEWSWIRE
Grace Announces Abstract Accepted for Presentation at SVIN Meet
11 Nov 2025 //
GLOBENEWSWIRE
Grace Therapeutics Secures $4.0M Via Warrant Exercises Post
23 Oct 2025 //
GLOBENEWSWIRE
Grace Therapeutics Secures 6th U.S. Patent for GTx-104
18 Sep 2025 //
GLOBENEWSWIRE
Grace Therapeutics Present at HC Wainwright Investment Conference
04 Sep 2025 //
GLOBENEWSWIRE
Grace Therapeutics to Join 2025 BIO International Conference
13 Jun 2025 //
GLOBENEWSWIRE
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
25 Oct 2024 //
GLOBENEWSWIRE
Acasti to Present at the Life Sciences Investor Forum
12 Sep 2024 //
GLOBENEWSWIRE
Legend Biotech looks to raise additional $350M in stock sale; Acasti to layoffs
08 May 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.